Published • loading... • Updated
Blood Pressure Medication Recalled as It May Be Ineffective, FDA Says
The Class II recall covers 30- and 90-count bottles after FDA testing found the tablets may not dissolve properly.
- New Jersey-based Macleods Pharma USA is recalling specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets after the medication failed to meet federal quality standards, according to the FDA.
- The FDA classified the action as a recall, meaning the medication "may cause temporary or medically reversible adverse health consequences," citing "failed dissolution specifications" as the reason.
- Consumers can check their prescription bottles for the lot number and National Drug Code, or NDC, as the recall affects bottles expiring May 31, 2027.
- This recall follows a September action involving India-based Inventia Healthcare Ltd., which recalled 13,567 bottles of 25-milligram tablets after that medication also failed dissolution testing, according to the FDA.
- Americans who take medication for high blood pressure may want to check their medicine cabinets, as the recall remains ongoing and affects products distributed nationwide.
Insights by Ground AI
12 Articles
12 Articles
Fox BusinessReposted by 
The New York Ledger
The New York LedgerThousands of blood pressure medication bottles recalled nationwide after pills fail quality test
Macleods Pharma USA is recalling thousands of bottles of a prescription blood pressure medication after the FDA said the drug failed dissolution specifications.
·New York, United States
Read Full Article
Coverage Details
Total News Sources12
Leaning Left1Leaning Right1Center10Last UpdatedBias Distribution84% Center
Bias Distribution
- 84% of the sources are Center
84% Center
C 84%
Factuality
To view factuality data please Upgrade to Premium
